SCHEMBL14616007

SCHEMBL14616007

COc1cc(OC)c(-c2ccccc2N)cc1CO

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDCD1 Q15116 2/20 0.46
CD274 Q9NZQ7 2/20 0.46
ALDH1A1 P00352 5/20 0.43
ADRA2B P18089 1/20 0.43
PTGS1 P23219 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.41
FGFR1 P11362 1/20 0.40
SRC P12931 1/20 0.40
PDE4A P27815 1/20 0.40
PDE4B Q07343 1/20 0.40
PDE4C Q08493 1/20 0.40
PDE4D Q08499 1/20 0.40
PKM P14618 1/20 0.39
RAD52 P43351 1/20 0.39
IDO1 P14902 1/20 0.39
EP300 Q09472 2/20 0.38
DRD2 P14416 1/20 0.38
DRD4 P21917 1/20 0.38
HRH1 P35367 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30279574 0.78 HTR7 (0.51) ALDH1A1ADRA2BPTGS1TDP1L3MBTL1
SCHEMBL5565297 0.76 ALDH1A1 (0.41) PDCD1CD274ALDH1A1ADRA2BPTGS1
SCHEMBL15624701 0.74 PDE4A (0.52) PDCD1CD274ALDH1A1TDP1L3MBTL1
SCHEMBL4069438 0.73 POLB (0.50) ALDH1A1ADRA2BPTGS1TDP1L3MBTL1
SCHEMBL395260 0.72 ALDH1A1 (0.67) ALDH1A1ADRA2BPTGS1TDP1L3MBTL1
SCHEMBL3794284 0.72 ALDH1A1 (0.59) PDCD1CD274ALDH1A1L3MBTL1IDO1
SCHEMBL3787198 0.71 ALDH1A1 (0.50) ALDH1A1ADRA2BPTGS1TDP1L3MBTL1
SCHEMBL3790445 0.71 ALDH1A1 (0.50) ALDH1A1ADRA2BPTGS1TDP1L3MBTL1
SCHEMBL95746 0.71 PDE4A (0.64) PDCD1CD274ALDH1A1TDP1L3MBTL1
SCHEMBL16156475 0.71 PDE4A (0.62) PDCD1CD274FGFR1SRCPDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7173129-B2 Sulfonamide-substituted chalcone derivatives and their use to treat diseases ATHERO GENICS, INC. (US) 2007-02-06 US disclosed